Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

98 articles published Follow:
MadeAi

MadeAI™ Sets New Benchmark for GenAI-Enabled GVD and JCA Reporting

MadeAi Press ReleaseNovember 10, 2025196Views0Likes0Comments
GLASGOW, SCOTLAND and CAMBRIDGE, MA, USA, November 10, 2025—At ISPOR Europe 2025 today, MadeAi™, the GenAI-powered evidence synthesis and report generation platform for life sciences, announced the launch of new capabilities designed to streamline and accelerate global value dossier (GVD) and Joint Clinical Assessment (JCA) submissions. With these advancements, MadeAi delivers the most comprehensive, AI-native…

Read More

Accuracy in GenAI-Based Literature Review Systems

Accuracy in GenAI-Based Literature Review Systems

White PaperNovember 6, 2025200Views0Likes0Comments
Accuracy and methodological rigor define the credibility of Gen-AI based literature review systems. AI reliability can be assessed through a measurable framework that minimizes hallucinations and ensures scientifically validated outcomes at every stage of evidence synthesis. Download Accuracy in GenAI-Based Literature Review Systems to discover the metrics, methodologies, and best practices shaping the next generation…

Read More

Real-Life Science

From Idea to Impact: AI Use Cases That Delivered Real-Life Sciences Business Results

BlogOctober 7, 2025257Views0Likes0Comments
Introduction Artificial Intelligence is redefining healthcare and life sciences. From improving patient care to accelerating drug discovery, AI is proving to be more than just a technological trend; it’s a critical enabler of innovation and efficiency. In this article, we explore real-world AI applications in clinical studies, pharmacovigilance, diagnostics, and medical operations. These use cases…

Read More

Unlock the ROI of GenAI-Enabled Literature Reviews

Unlock the ROI of GenAI-Enabled Literature Reviews

White PaperSeptember 18, 2025295Views0Likes0Comments
Traditional literature reviews are slow, expensive, and resource-intensive. AI-powered literature reviews streamline evidence synthesis, accelerating timelines while maintaining methodological rigor and transparency. With both self-service and full-service options, AI helps life sciences teams reduce workloads and costs while delivering high-quality results faster. Download Unlock the ROI of GenAI-Enabled Literature Reviews to see how GenAI transforms literature…

Read More

AI in Evidence Generation

How HTA Agencies Are Evaluating AI in Evidence Generation

BlogSeptember 8, 2025257Views0Likes0Comments
As AI rapidly reshapes the evidence landscape, health technology assessment (HTA) bodies are beginning to define clear expectations for its use in submissions. At CapeStart, we work closely with life sciences clients navigating these changes—especially those integrating GenAI into literature reviews, RWE generation, economic modeling, Joint Clinical Assessment (JCA) support, Clinical Evaluation Reports (CERs), Patient…

Read More

Stevie Award

CapeStart’s MadeAI™ Wins Stevie® Award for Second Consecutive Year – 2025

MadeAi Press ReleaseAugust 25, 2025287Views0Likes0Comments
Newest version of MadeAi™ for content synthesis hailed by judges as “a significant leap in applying Generative AI to the life sciences”   Cambridge, MA, August 25, 2025—CapeStart, an AI solutions and services firm, announced that its CapeStart MadeAi™ GenAI Platform for Life Sciences Content Synthesis was a winner of a Stevie® Award in The…

Read More